Funding for this research was provided by:
First Online: 30 April 2019
: CP is a named inventor on a patent application entitled ‘Proteogenomic-based method for identifying tumor-specific antigens’ filed by Université de Montréal. GE has no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.